March, 2021
Ito2019 - Gefitinib resistance of lung adenocarcinoma caused by MET amplification
Model(s) associated with this Model of the Month: BIOMD0000000827
Last updated by: Krishna Kumar Tiwari
BioModels is a repository of mathematical models of biological and biomedical systems. It hosts a vast selection of existing literature-based physiologically and pharmaceutically relevant mechanistic models in standard formats. Our mission is to provide the systems modelling community with reproducible, high-quality, freely-accessible models published in the scientific literature. More information about using BioModels such as model submission, update, publication can be found in the FAQ.
March, 2021
It's a mechanistic ODE model exploring the mechanism responsible for Gefitinib (Epidermal growth factor receptor-Tyrosine Kinase inhibitor (EGFR-TKI)) resistance in MET (MET proto-oncogene, receptor tyrosine kinase) amplified lung adenocarcinoma.
Model(s) associated with this Model of the Month: BIOMD0000000827
Last updated by: Krishna Kumar Tiwari
BioModels provides online courses, please consult more information.